Learn more about whether Jabil Inc. or TD SYNNEX Corporation is a better investment based on AAII's A+ Investor grades, which ...

Chicago Partners Investment Group LLC purchased a new stake in Jabil Inc. (NYSE:JBL – Free Report) during the 4th quarter, ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii) to offer support for drug development customers. The acquisition of Pii enhances ...

Jabil Inc. has a 12-month low of $95.85 and a 12-month high of $174.80. The stock has a market capitalization of $17.84 billion, a price-to-earnings ratio of 15.67, a PEG ratio of 1.61 and a beta ...

The stock's fall snapped an eight-day winning streak.

The manufacturer has been exploring a sale since 2023. STORY HIGHLIGHTS Jabil Inc. acquired Pharmaceutics International Inc. on Feb. 3. Pharmaceutics operates a 360,000-square-foot campus in Hunt ...

Jabil Inc. closed 6.96% short of its 52-week high of $174.80, which the company achieved on January 24th.

An investor group led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc have sold their equity stake in Pharmaceutics International, Inc, a Hunt Valley, ...

ST. PETERSBURG, Fla., January 15, 2025--(BUSINESS WIRE)--Jabil Inc. (NYSE: JBL) today announced it will host its Annual Meeting of Stockholders in a virtual only format on January 23, 2025 ...